Cancer Database Query Results

Scientific Papers found: Click to Expand⟱
5827- CAP,    The Effect of Topical Capsaicin 8% on Pain in Chemotherapy-induced Peripheral Neuropathy
- Trial, Var, NA
Pain↓, NP/CIPN↓, Dose↝, TRPV1↑, Ca+2↑,
5822- capec,    Capecitabine as Adjuvant Treatment for Stage III Colon Cancer
- Trial, Colon, NA
OS↑, eff↑,
5821- capec,  docx,    Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results
- Trial, BC, NA
eff↑, OS↑,
5883- CAR,    Safety and tolerability of carvacrol in healthy subjects: a phase I clinical study
- Trial, Nor, NA
*Dose↝, *HDL↓, *Bil↓, *Iron↓, *toxicity↓,
5889- CAR,    Effect of carvacrol on pulmonary function tests, and total and differential white blood cell counts in healthy volunteers: A randomized clinical trial
- Trial, Nor, NA
*Dose↝, *toxicity∅,
3880- Carno,    EFFECT OF ANSERINE/CARNOSINE SUPPLEMENTATION ON THE PREVENTION OF ALZHEIMER'S DISEASE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT
- Trial, AD, NA
*cognitive↑, *other↑,
5929- Catechins,    Phase I trial of oral green tea extract in adult patients with solid tumors
- Trial, Var, NA
Dose↑, toxicity↝,
5930- Catechins,    Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention
- Trial, Pca, NA
PSA↓, other↑, Risk↝,
5916- Cats,  Chemo,    Uncaria tomentosa—Adjuvant Treatment for Breast Cancer: Clinical Trial
- Trial, BC, NA
*DNAdam↓, Neut↓, eff↑, Imm↑, Dose↝,
5917- Cats,    Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial
- Trial, CRC, NA
Dose↝, *DNArepair↑, toxicity↝, BioAv↝, eff∅,
5918- Cats,    Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors
- Trial, Var, NA
Dose↝, QoL↑, fatigue↓,
5812- CBD,    Cannabidiol oil or placebo in advanced cancer-disease progression and survival: a secondary analysis
- Trial, Var, NA
other∅, OS∅, other∅,
5966- CEL,    Determine whether administering celecoxib during radiotherapy can reduce the risk of recurrence of triple-negative breast cancer. Pilot study
- Trial, BC, NA
Risk↓, eff↑,
5960- CEL,    Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers
- Trial, Pca, NA
eff∅, Dose↝, CardioT↑,
6635- Cen,    Pharmacokinetics and metabolomics investigation of an orally modified formula of standardized Centella asiatica extract in healthy volunteers
- Trial, Nor, NA
*BioAv↝, *eff↑, *Choline↑, *memory↑, *cognitive↑, *neuroP↑, *BioAv↑,
6636- Cen,    Pharmacokinetics and Pharmacodynamics of Key Components of a Standardized Centella asiatica Product in Cognitively Impaired Older Adults: A Phase 1, Double-Blind, Randomized Clinical Trial
- Trial, AD, NA
*cognitive↑, *NRF2↑, *Dose↝, *memory↑, *ROS↓, *mitResp↑, *neuroP↑, *Half-Life↝, *Half-Life↝, *Half-Life↝,
6659- Cen,    Effect of Centella asiatica on mild cognitive impairment (MCI) and other common age-related clinical problems
- Trial, AD, NA
*Dose↝, *cognitive↑, *Sleep↑,
6657- Cen,    Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
- Trial, AD, NA
*Dose↝,
6646- Cen,    Effectiveness of Gotu Kola Extract 750 mg and 1000 mg Compared with Folic Acid 3 mg in Improving Vascular Cognitive Impairment after Stroke
- Trial, Stroke, NA
*eff↑, *memory↑, *cognitive↑, *AST∅, *ALAT∅, *AChE↓, *toxicity↓,
5972- CET,  Rad,    Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer
- Trial, HNSCC, NA
OS↑,
6024- CGA,    Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up
- Trial, GBM, NA
*toxicity↓, Half-Life↝, BBB↑,
6041- CGA,    Effect of Chlorogenic Acid Intake on Cognitive Function in the Elderly: A Pilot Study
- Trial, AD, NA
*Dose↝, *memory↑, *Risk↓, *cognitive↑, *Aβ↓, *antiOx↓, *motorD↑,
6036- CGA,    Effect of Chlorogenic Acids on Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial
- Trial, Nor, NA
*motorD↑, *cognitive↑, *eff↑,
6035- CGA,    Effect of Chlorogenic Acids on Cognitive Function in Mild Cognitive Impairment: A Randomized Controlled Crossover Trial
- Trial, Nor, NA
*Dose↝, *cognitive↑, *Risk↓, *AChE↓, *ROS↓,
6029- CGA,    Pharmacokinetics of chlorogenic acids absorbed in human plasma and their metabolites following oral ingestion of coffee drink
- Trial, Nor, NA
*Dose↝, *BioAv↑, *Half-Life↝,
6028- CGA,    Chlorogenic acids from green coffee extract are highly bioavailable in humans
- Trial, Nor, NA
*BioAv↑, *Dose↝,
5998- Chit,    Trial: Chitosan can help reduce AGE levels in patients with prostate cancer.
- Trial, Pca, NA
AGEs↓, Wound Healing↑, Obesity↓,
4476- Chit,    Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial
- Trial, NA, NA
*LDL↓,
6071- CHL,    First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent
- Trial, Nor, NA
*Dose↑, *toxicity↓, *Imm↑,
6087- CHOC,    Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial
- Trial, Nor, NA
*cardioP↑, *Dose↝, *BP↓, *Inflam↓, *AntiAg↑, *Risk↓,
6088- CHOC,    Effect of chocolate on older patients with cancer in palliative care: a randomised controlled study
- Trial, Var, NA
eff↑, *ROS↓, *MDA↓, *GSH↑,
6089- CHOC,    Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study—a randomized controlled trial
- Trial, Nor, NA
*Dose↝, *BP↓, *cognitive↑,
6150- Chol,    Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial
- Trial, AD, NA
*cognitive↑,
6117- Chol,    Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Trial, AD, NA
*memory↑, *TMAO∅, *Dose↝,
6120- Chol,    Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease
- Trial, AD, NA
*Dose↝, *cognitive↑, *QoL?,
6134- CHr,  QC,  RT,    Comparative Pharmacokinetics and Safety of a Micellar Chrysin–Quercetin–Rutin Formulation: A Randomized Crossover Trial
- Trial, Nor, NA
Dose↝, BioAv↑, MPT↑, eff↑, Half-Life↑,
7433- Chy,    Evaluation of Cyavanaprāśa on Health and Immunity related Parameters in Healthy Children: A Two Arm, Randomized, Open Labeled, Prospective, Multicenter, Clinical Study
- Trial, Nor, NA
*Dose↝, *QoL↑, *Imm↑,
7432- Chy,    A Cytogenetic Study on the Efficacy of Chyawanprash Awaleha as an Antioxidant in Oral Premalignant Cancer
- Trial, Oral, NA
Dose↝, Risk↓,
4257- CoQ10,    Dietary intake of coenzyme Q10 reduces oxidative stress in patients with acute ischemic stroke: a double-blind, randomized placebo-controlled study
- Trial, Stroke, NA
*MDA↓, *IL6↓, *SOD↑, *BDNF↑, *ROS↓, *Inflam↓, *neuroP↑,
6152- CoQ10,  doxoR,    Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment
- Trial, BC, NA
eff↝, CardioT↝, ROS↝, ROS↝, ROS↓,
6368- CPLE,    Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial
- Trial, Var, NA
PC↑,
6369- CPLE,    Carica papaya leaf extract (CPLE) versus placebo to improve chemotherapy induced thrombocytopenia (CIT): Results of a phase III triple blinded, randomized placebo controlled trial (PACT study).
- Trial, Var, NA
PC↑, other↝, CIT↓,
3625- Cro,    Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial
- Trial, AD, NA
*Aβ↓, *cognitive↑,
3626- Cro,    Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
- Trial, AD, NA
*cognitive↓,
3634- Cro,    A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease
- Trial, AD, NA
*cognitive↑,
7421- CS,    Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial
- Trial, Nor, NA
*hepatoP↑, *Dose↝, *toxicity↓, *BloodF↑, *ALAT↓, *AST↓, *Bil↓, *LDL↓, *HDL↓, *TG/TAG↓,
7417- CS,  CGA,    Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans
- Trial, Nor, NA
Dose↝, BioAv↝, Half-Life↝,
7419- CS,    Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial
- Trial, Nor, NA
*Dose↝, *other↓,
7420- CS,    Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial
- Trial, Obesity, NA
*LDL↓, *HDL↑, Dose↝,
6226- CUR,  Rad,    Analysis of Curcumin as a Radiosensitizer in Cancer Therapy with Serum Survivin Examination: Randomised Control Trial
- Trial, Cerv, NA
survivin↓, RadioS↑, toxicity↓,

Showing Research Papers: 51 to 100 of 435
Prev Page 2 of 9 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 435

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

2/16-OHE1↑, 1,   8-oxo-dG↓, 1,   ADCY4↑, 1,   AEs∅, 1,   APG↓, 2,   CIT↓, 1,   CR↑, 2,   DCR↑, 3,   DCR↝, 1,   ENL↑, 1,   IGF-2R↑, 1,   Ingr↑, 1,   JAG1↑, 1,   LC↑, 1,   mal↓, 1,   miR-106b↓, 1,   Mucositis↓, 4,   Nausea↓, 4,   Nausea∅, 2,   NEU1↑, 1,   NLR↓, 1,   ORR↑, 3,   ORR∅, 1,   PC↑, 3,   PFS↑, 4,   PFS∅, 1,   PGI2↓, 1,   RBC↑, 3,   RFS↑, 1,   TTP↑, 1,   UFR↑, 1,   Vomit↓, 4,   Vomit∅, 2,   WBC↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Bil∅, 1,   Copper↓, 2,   CoQ10↑, 1,   GSH↓, 1,   MDA↓, 1,   ROS↓, 3,   ROS↑, 5,   ROS↝, 2,   SOD↑, 1,   TrxR↓, 1,   VitC↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR-ABL↓, 1,   Insulin↓, 2,   MPT↑, 1,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 2,   BUN↓, 1,   CYP3A4⇅, 1,   FAO↑, 1,   lactateProd↓, 1,   PDK1 / PDPK1↓, 2,   PPARγ↓, 1,  

Cell Death(tgid=5) ⓘ

p‑Akt↓, 1,   Apoptosis↑, 6,   Bcl-2↓, 3,   Bcl-xL↓, 2,   Cyt‑c↝, 1,   IAP1↓, 1,   Mcl-1↓, 3,   Myc↓, 1,   NOXA↑, 1,   PUMA↑, 1,   survivin↓, 1,   TRPV1↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

miR-30a-5p↑, 1,   other?, 1,   other↓, 4,   other↑, 6,   other↝, 18,   other∅, 3,   SD↑, 4,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

NKX3.1↓, 1,   P53↑, 1,   RAD51↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cycD1/CCND1↓, 2,   P21↑, 3,   TumCCA↑, 5,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 1,   CSCs↓, 2,   HDAC↓, 4,   HH↓, 3,   HH∅, 1,   IGF-1↓, 7,   IGF-1↑, 1,   IGFBP1↑, 2,   IGFBP3↓, 1,   IGFBP3↑, 1,   IGFR↓, 1,   NOTCH3↑, 1,   PI3K↓, 1,   PTEN↑, 2,   Smo↓, 1,   TumCG↓, 7,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

5LO↓, 1,   AntiAg↑, 1,   AntiAg↝, 1,   AntiAg∅, 1,   Ca+2↓, 1,   Ca+2↑, 1,   GLI3↓, 1,   Ki-67↓, 6,   miR-19b↓, 1,   miR-29b↑, 1,   MMP2↓, 1,   MMP9↓, 2,   MMP9:TIMP1↑, 1,   Slug↓, 1,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   TGF-β↓, 1,   TIMP1↓, 1,   TumCA↓, 1,   TumCI↓, 3,   TumCMig↓, 2,   TumCP↓, 9,   TumMeta↓, 1,   TumMeta↑, 1,   Twist↓, 1,   Vim↓, 1,   ZO-1↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 8,   angioG∅, 1,   EGFR↓, 3,   Endoglin↓, 1,   Hif1a↓, 1,   VEGF↓, 3,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,   P-gp/ABCB1↓, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↓, 1,   CD25+↓, 1,   CD4+↓, 1,   CD4+↑, 1,   cellSen?, 1,   COX2/PTGS2↓, 4,   COX2/PTGS2∅, 1,   CRP↓, 2,   FoxP3+↓, 1,   GM-CSF↓, 1,   IFN-γ↑, 1,   IL10↓, 1,   IL12↓, 1,   IL18↑, 1,   IL1β↓, 1,   IL1β∅, 1,   IL22↓, 1,   IL6↓, 4,   Imm↑, 11,   INF-γ↝, 1,   Inflam↓, 7,   LIF↑, 1,   MCP1/CCL2↓, 1,   Neut↓, 1,   Neut↑, 2,   NF-kB↓, 2,   NK cell↑, 4,   PDT+↓, 1,   PGE2↓, 2,   PSA↓, 10,   T-Cell↑, 1,   TNF-α↓, 1,   TNF-α∅, 1,   VitD↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 2,   AR↝, 1,   DHT↓, 1,   EstroRS/ERS↑, 1,   testos↓, 1,   testos∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 9,   BioAv↝, 8,   BioEnh↑, 1,   ChemoSen↑, 6,   ChemoSen∅, 1,   CYP1A2↑, 1,   Dose?, 2,   Dose↓, 3,   Dose↑, 7,   Dose↝, 117,   Dose∅, 4,   eff↓, 2,   eff↑, 42,   eff↝, 6,   eff∅, 7,   Half-Life↑, 1,   Half-Life↝, 6,   RadioS↑, 4,   selectivity↑, 5,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   ALC↓, 1,   AR↓, 2,   AR↝, 1,   AST↓, 2,   BG↓, 1,   Bil∅, 1,   CA125↓, 1,   CA125∅, 1,   CA19-9↓, 1,   CEC↝, 1,   creat↓, 1,   CRP↓, 2,   CTC↓, 1,   EGFR↓, 3,   EstroRS/ERS↑, 1,   GutMicro↑, 1,   HemoG↑, 1,   IL6↓, 4,   Ki-67↓, 6,   Myc↓, 1,   PSA↓, 10,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 6,   antiNeop↑, 1,   AntiTum↑, 3,   AntiTum∅, 1,   cachexia↓, 1,   cardioP↑, 3,   CardioT↑, 1,   CardioT↝, 1,   chemoP↑, 6,   chemoP∅, 1,   chemoPv↑, 5,   ChemoSideEff↓, 2,   fatigue↓, 3,   hepatoP↓, 1,   hepatoP↑, 2,   memory↑, 1,   NP/CIPN↓, 2,   NP/CIPN↑, 3,   Obesity↓, 1,   OS?, 1,   OS↑, 48,   OS↝, 1,   OS∅, 9,   Pain↓, 8,   QoL↑, 16,   QoL∅, 3,   radioP?, 1,   radioP↑, 5,   radioP↝, 1,   Remission↑, 3,   Risk↓, 13,   Risk↑, 2,   Risk↝, 2,   Risk∅, 4,   stomatitis↓, 1,   Strength↑, 1,   Strength∅, 1,   toxicity↓, 25,   toxicity↑, 1,   toxicity↝, 19,   toxicity∅, 1,   TumVol↓, 4,   TumW↓, 1,   Weight↑, 5,   Weight∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

CD8+↑, 3,   Diar↓, 1,   Diar⇅, 1,   Inf↓, 4,   Sepsis↓, 1,  
Total Targets: 277

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

12-HETE↓, 1,   2/16-OHE1↑, 1,   5-HETE↓, 1,   AcOH↑, 2,   AntiBio↑, 2,   BDI↓, 1,   Buty↑, 3,   CCr / CrCl↓, 1,   CCr / CrCl∅, 1,   Eic↓, 1,   END↑, 1,   ENL↑, 1,   Eos↓, 1,   FEV1↑, 2,   FFA/NEFA↝, 1,   HRV↑, 1,   IgE↓, 1,   Ingr↝, 1,   IPSS↓, 1,   Learn↑, 1,   NLR↓, 1,   NMSS↓, 1,   PA↑, 2,   PCO↓, 1,   PEF↑, 1,   rHR↓, 1,   RT↓, 2,   SCFAs↑, 3,   SCFAs∅, 1,   Stress↓, 4,   Tinn↓, 1,   TMAO∅, 1,   UFR↑, 1,   UPDRS↓, 1,   UPDRSIII∅, 1,   UR↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 11,   Bil↓, 2,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 5,   HDL↓, 2,   HDL↑, 4,   HO-1↑, 1,   Iron↓, 1,   lipid-P↓, 2,   MDA↓, 4,   MDA↑, 1,   MPOD↑, 2,   NRF2↑, 2,   ROS↓, 16,   SAM-e↓, 1,   SOD↑, 3,   TAC↑, 3,   TBARS↓, 1,   uricA↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mitResp↑, 1,   mtDam↓, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACLY↓, 1,   adiP↑, 1,   ALAT↓, 3,   ALAT∅, 1,   AMPK↑, 1,   CRM↑, 1,   DHA↑, 2,   glucose∅, 1,   KeyT↝, 1,   lactateProd↓, 1,   LDH↓, 3,   LDL↓, 9,   NH3↓, 1,   SIRT1↑, 1,  

Cell Death(tgid=5) ⓘ

BAX↓, 1,   Casp3↓, 1,   CK2↓, 1,   p38↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

Ach↑, 2,   AntiThr↑, 3,   other?, 3,   other↓, 3,   other↑, 16,   other↝, 14,   other∅, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   DNArepair↑, 1,   DNMT3A↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Choline↑, 1,   Diff↝, 1,   EP2↑, 1,   HDAC3↓, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↓, 1,   NOTCH↓, 1,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AntiAg∅, 1,   MMP9↓, 1,   TGF-β↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,   TXA2↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↑, 1,   COX1↓, 1,   CRP↓, 4,   IFN-γ↓, 1,   IFN-γ↑, 3,   IL1↓, 1,   IL10↓, 1,   IL10↑, 1,   IL10∅, 1,   IL12↓, 1,   IL17∅, 1,   IL1β↓, 5,   IL4↑, 1,   IL4∅, 1,   IL6↓, 9,   IL8↓, 1,   Imm↑, 5,   Inflam↓, 23,   MCP1/CCL2↓, 1,   MCP1/CCL2↝, 1,   NF-kB↓, 1,   NK cell↑, 3,   PGE2↓, 2,   PSA↓, 1,   TNF-α↓, 8,   TNF-α↑, 3,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 3,   AChE↓, 4,   BDNF↑, 7,   BDNF∅, 1,   BrainVol↑, 1,   BrainVol↝, 1,   BrainVol∅, 3,   GABA↑, 1,   tau↓, 3,   p‑tau↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 10,   Aβ∅, 1,   BACE/β-secretase↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

cortisol↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 4,   BioAv↑, 18,   BioAv↝, 12,   Dose?, 6,   Dose↓, 1,   Dose↑, 7,   Dose↝, 111,   eff↓, 1,   eff↑, 21,   eff↝, 7,   eff∅, 1,   Half-Life↓, 2,   Half-Life↑, 2,   Half-Life↝, 19,   P450↓, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 3,   ALAT∅, 1,   Albumin↑, 2,   ALP↓, 1,   AST↓, 1,   AST∅, 1,   Bil↓, 2,   BloodF↑, 3,   BMD↑, 1,   BP↓, 12,   BP∅, 1,   CRP↓, 4,   GutMicro↑, 6,   GutMicro∅, 1,   Hcy/homoC↓, 13,   Hcy/homoC↝, 1,   HemoG↑, 1,   hs-CRP↓, 1,   IL6↓, 9,   LDH↓, 3,   PSA↓, 1,   TG/TAG↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↑, 2,   AntiDiabetic↑, 2,   AntiTum↑, 3,   ANXi↓, 2,   cardioP↑, 5,   chemoP↑, 3,   cognitive?, 1,   cognitive↓, 1,   cognitive↑, 68,   cognitive↝, 2,   cognitive∅, 12,   fatigue↓, 2,   GFR↓, 1,   GFR∅, 1,   hepatoP↑, 5,   memory↑, 23,   memory∅, 1,   Mood↑, 7,   motorD↑, 9,   MusCon↓, 1,   neuroP↑, 12,   Obesity↓, 2,   Pain↓, 8,   QoL?, 1,   QoL↑, 10,   RenoP↑, 3,   Risk↓, 5,   Risk↑, 2,   Risk↝, 1,   Sleep↑, 6,   Strength↑, 4,   toxicity?, 1,   toxicity↓, 31,   toxicity↑, 1,   toxicity↝, 3,   toxicity∅, 7,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 2,   AntiViral↑, 4,   Bacteria↓, 2,  
Total Targets: 227

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page